ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome
Phase 2
Completed
- Conditions
- LeukemiaMyelodysplastic SyndromesNonmalignant NeoplasmParoxysmal Nocturnal Hemoglobinuria
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2015-12-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT00731328
- Locations
- 🇰🇷
Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome
Phase 2
Completed
- Conditions
- LeukemiaMyelodysplastic Syndromes
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2012-07-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 54
- Registration Number
- NCT00732316
- Locations
- 🇰🇷
Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment
- First Posted Date
- 2008-08-07
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 54
- Registration Number
- NCT00729482
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa, Korea, Republic of
Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
Phase 4
- Conditions
- Ocular Behcet's Disease,Non-Infectious UveitisRefractory Uveitis
- Interventions
- Drug: flucinolone acetonide
- First Posted Date
- 2008-07-23
- Last Posted Date
- 2008-07-29
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT00720928
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization
Phase 2
Completed
- Conditions
- Procedure-Related ComplicationDegree of Liver Regeneration
- Interventions
- Procedure: Right hepatic vein embolization
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2008-06-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 13
- Registration Number
- NCT00698880
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 232
- Registration Number
- NCT00696761
Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas
Phase 2
- Conditions
- Cystic Tumors of the Pancreas
- Interventions
- Procedure: Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2016-07-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00689715
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Latent Tuberculosis Infection in Renal Transplant Recipients
Completed
- Conditions
- Renal Transplant
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2010-06-02
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 240
- Registration Number
- NCT00682045
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
- First Posted Date
- 2008-03-17
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00637091
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection
Phase 2
Completed
- Conditions
- Hypocalcemia
- Interventions
- Dietary Supplement: Oral calcium plus vitamin DDietary Supplement: Oral calcium alone
- First Posted Date
- 2008-03-06
- Last Posted Date
- 2008-03-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT00630214
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath